GlassScriptPhysician profile
Mohammad Raza Khan
NPI 1811507775
$1,991.02
in general payments reported to CMS, 2019-2025
15 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $56.19 · 2021: $24.92 · 2022: $1,182 · 2023: $320 · 2024: $141 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $727.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $1,160.75 | 2020-2025 | Physio-Stim |
| Stryker Corporation | $196.81 | 2020-2023 | Augment Injectable |
| Horizon Therapeutics Plc | $124.71 | 2023 | Krystexxa |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Medtronic, INC. | $77.90 | 2025 | Inceptiv |
| Treace Medical Concepts, INC. | $74.10 | 2025 | |
| Medshape, INC. | $65.40 | 2024 | Dynanail |
| Abbvie INC. | $57.14 | 2023-2024 | |
| Teva Pharmaceuticals USA, INC. | $36.30 | 2024 | Uzedy |
| Paratek Pharmaceuticals, INC. | $35.95 | 2025 | Nuzyra |
| Pylant Medical | $22.88 | 2025 | |
| Janssen Pharmaceuticals, INC | $21.57 | 2025 | Spravato |
| Globus Medical, INC. | $15.96 | 2025 | Senza |
| Melinta Therapeutics, LLC | $11.72 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.